1,3-Butadiene, CML and the t(9:22) translocation: A reality check

Area of Science:

• Toxicology
• Genetics
• Oncology

Background:

• Epidemiological studies suggest a link between 1,3-butadiene exposure and chronic myeloid leukemia (CML).
• CML is associated with ionizing radiation, which can induce the t(9:22) translocation (Philadelphia chromosome).
• Chemical induction of the Philadelphia chromosome has not been demonstrated, questioning chemical links to CML.

Purpose of the Study:

• To establish a positive control for in vitro studies investigating the CML-associated t(9:22) translocation.
• To assess the capacity of ionizing radiation to induce pathogenic translocations in a human myeloid cell line.
• To determine conditions for future studies on 1,3-butadiene metabolites and their potential to induce CML-associated translocations.

Main Methods:

• Utilized ionizing radiation as a positive control agent.
• Exposed a human myeloid cell line in vitro.
• Quantified the induction frequency of t(9:22) translocations.

Main Results:

• Ionizing radiation successfully induced pathogenic t(9:22) translocations in the human myeloid cell line.
• The induction frequency of these translocations by ionizing radiation was observed to be low.
• Established conditions necessary for future investigations into 1,3-butadiene's genotoxic effects.

Conclusions:

• Ionizing radiation serves as a viable, albeit low-frequency, positive control for inducing CML-associated translocations in vitro.
• The established methodology provides a framework for testing the genotoxicity of chemical exposures, like 1,3-butadiene metabolites.
• Further research is warranted to explore the potential of 1,3-butadiene metabolites in inducing CML-associated translocations.